Domov › Rak prostate › Nebraska › Omaha
Klinične študije za Rak prostate v Omaha, NE
27 študij za Rak prostate išče udeležence na lokacijah v Omaha in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Vključevanje udeležencevFaza 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi stran
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Urology Cancer Center, PC, Omaha
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Vključevanje udeležencevFaza 3
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026), Omaha
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Vključevanje udeležencevFaza 2/3
- Nebraska Cancer Specialists, Omaha
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Vključevanje udeležencevFaza 3
- Nebraska Cancer Specialists, Omaha
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Vključevanje udeležencevFaza 2
- University of Nebraska Medical Center, Omaha
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- XCancer, Omaha
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Vključevanje udeležencevFaza 3
- XCancer Omaha LLC, Omaha
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Vključevanje udeležencevFaza 3
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi stran
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Research Site, Omaha
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Vključevanje udeležencevFaza 3
- Research Site, Omaha
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Vključevanje udeležencevFaza 2
- XCancer Omaha, Omaha
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Vključevanje udeležencevFaza 1/2
- Nebraska Cancer Specialists, Omaha
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Vključevanje udeležencevFaza 3
- Alegent Health Bergan Mercy Medical Center, Omaha
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Vključevanje udeležencevFaza 2
- University of Nebraska Medical Center, Omaha
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Vključevanje udeležencevFaza 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Integrated Cancer Repository for Cancer Research
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- in še 1
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Vključevanje udeležencevFaza 1
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Vključevanje udeležencevFaza 4
- Urology Cancer Center PC, Omaha
- Nebraska Cancer Specialists, Omaha
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Vključevanje udeležencevFaza 1/2
- XCancer Omaha / Urology Cancer Center, Omaha
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- Research Site, Omaha
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Vključevanje udeležencevFaza 2
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- in še 3
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Vključevanje udeležencevFaza 3
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi stran
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
Vključevanje udeležencev
- University of Nebraska Medical Center, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Omaha
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 3
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- in še 1
Študije za Rak prostate v drugih mestih
- New York City, NY103 študij
- Houston, TX76 študij
- Los Angeles, CA61 študij
- Boston, MA59 študij
- St. Louis, MO46 študij
- Chicago, IL45 študij
- San Francisco, CA45 študij
- Philadelphia, PA44 študij
- Baltimore, MD43 študij
- Nashville, TN42 študij
- Seattle, WA42 študij
- Washington, DC38 študij
Druge študije v Omaha
- Nemalicelični pljučni rak24 študij
- Rak dojke22 študij
- Kolorektalni rak18 študij
- Rak (vse vrste)18 študij
- Množni mielom16 študij
- Non-Hodgkinov limfom14 študij
- Rak jajčnikov14 študij
- Rak trebušne slinavke14 študij
- Ploščatocelični karcinom glave in vratu13 študij
- Srčno popuščanje13 študij
- Metastatski rak13 študij
- Rak ledvic (renocelularni karcinom)12 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.